β-glucan in the diagnosis of invasive fungal disease

Clinical Infectious Diseases

Volumn 47, Issue 2, 2008, Pages 292-293

  Pasqualotto, Alessandro C ^a,b   Sukiennik, Teresa C T ^a  

^a Santa Casa Complexo Hospitalar   (Brazil)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GLUCAN;

ASPERGILLOSIS; ASPERGILLUS; CANDIDA; FUNGUS IDENTIFICATION; HUMAN; INVASIVE CANDIDIASIS; LETTER; MYCOSIS; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY;

EID: 46349098383     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/589571     Document Type: Letter

References (3)

1. Senn L, Robinson JO, Schmidt S, et al. 1,3-β-D-Glucan antigenemia for early diagnosis of invasive fungal infections in neutropenic patients with acute leukemia. Clin Infect Dis 2008; 46:878-85.
2. Herbrecht R, Berceanu A. β-Glucan detection test: a step toward preemptive therapy for fungal infections in leukemic patients? Clin Infect Dis 2008; 46:886-9.
3. Ostrosky-Zeichner L, Alexander BD, Kett DH, et al. Multicenter clinical evaluation of the (1→3) β-D-glucan assay as an aid to diagnosis of fungal infections in humans. Clin Infect Dis 2005; 41:654-9.